Brand Establishment and Development Strategies Based on the Inheritance of Traditional Chinese Medicine Culture: The Case of “Jianchang Bang”
Abstract
With the deepening implementation of the "Healthy China" strategy and the "Healthy Jiangxi" strategy, Jiangxi Province has incorporated the traditional Chinese medicine (TCM) industry into its key development areas, aiming to establish a distinctive regional Chinese medicine industry cluster in southern China. As a living heritage carrier of Jiangxi's TCM culture, the national-level intangible cultural heritage "Jianchang Bang" Chinese medicinal "paozhi" (processing) techniques demonstrate unique advantages in enhancing medicinal efficacy and reducing toxicity through its four characteristic "paozhi" methods—roasting, simmering, and decocting—as well as its comprehensive "paozhi" standards encompassing "form, color, aroma, and taste". However, facing the impact of modern pharmaceutical technologies, this craftsmanship confronts developmental bottlenecks such as fractured inheritance chains, insufficient standardization of techniques, and limited brand recognition. This study employs a Strengths-Weaknesses-Opportunities-Threats (SWOT) analysis to systematically examine the brand's current development status, core challenges, and constraining factors. It proposes targeted countermeasures and recommendations for the brand construction and development of "Jianchang Bang", formulates optimized brand enhancement pathways, and thereby innovates the development level of Jiangxi's Chinese medicinal materials industry.
References
[2] Shi, S., Liao, L., & Zhu, L. (1826). Daoguang Nancheng County annals (Vol. 25, Pt. 1). Jianchang: Nancheng County Archives of Jiangxi Province.
[3] Xia, S. (1964). Zhengde Jianchang Prefecture annals. Shanghai: Shanghai Ancient Books Publishing House.
[4] Chinese Taoist Association & Suzhou Taoist Association. (1993). Taoist dictionary (p. 320). Beijing: Huaxia Publishing House.
[5] Guo, S., He, Q., Zhou, T., Liu, S., & He, P. (2021). Research on the development history and processing characteristics of the Jianchang Bang. Jiangxi Traditional Chinese Medicine Modern Distance Education, 19(6), 80–82.
[6] Chen, X. (1994). Chronology of Chinese pharmaceutical history (p. 42). Beijing: China Medical Science and Technology Press.
[7] Xia, S. (1964). Zhengde Jianchang Prefecture annals (Vol. 10, Pt. 4). Reprinted from the Zhengde edition of the Tianyige Library in Ningbo. Shanghai: Shanghai Ancient Books Publishing House.
[8] Mei, K. (1985). A brief history of the “Jianchang Bang” of Chinese medicine. Chinese Medical History, 15(1), 29.
[9] Shi, K. (2019). The rise of Chinese medicine brands in China. Commercial Culture, 14, 76–81.
[10] Zhang, X. (2020). Research on the brand building of LJ Company under the background of great health [Master’s thesis, Northwest A&F University]. Yangling.
[11] Wang, J., Li, X., Pan, X., et al. (2017). Research on the construction of regional brands in the Chinese medicine industry. World Chinese Medicine, 12(11), 2799–2802.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright for this article is retained by the author(s), with first publication rights granted to the journal.
This is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).